Major study launches to track teen eczema treatments
NCT ID NCT06238765
Summary
This study aims to track the long-term safety and effectiveness of eczema treatments in teenagers. It will follow about 1,500 adolescents aged 12-15 with moderate to severe eczema who are starting a new medication. The goal is to collect real-world information to help doctors, patients, and regulators understand how well these treatments work over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CorEvitas, LLC
RECRUITINGWaltham, Massachusetts, 02451, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.